H|T: The Healthtech Times – Recursion secures $50M from Nvidia following Canadian drug-discovery acquisitions
Plus: Ditch Labs wants to treat nicotine addiction with tech.
Plus: Ditch Labs wants to treat nicotine addiction with tech.
Plus: Sampler acquires Admass’s tech to integrate UGC and AI into platform.
Plus: Shopify is building entrepreneurs an AI Sidekick.
Plus: Experts and VCs disagree on the actual perils of AI.
Startups, regulator have been embroiled in a dispute over the title for years.
Initial phase will focus on early-stage, women-led businesses with social impact.
GreatPoint-backed Shakudo is led by AI experts from Georgian, Borealis AI, and BMO.
Plus: Babylon will cease trading on NYSE, combine with MindMaze.
Plus: Alibaba surprises with chairman and CEO replacement.
Plus: Poka to be acquired in reported $200M deal.
Plus: Angel investment in Canada mirrored VC dip in 2022.
Plus: Shopify partners with Volt to offer open banking solutions (but not in Canada).
While deal count rose, angels disproportionately favoured existing portfolio firms.
Attendees from the GTA can board the Startup Train to get to the Montréal festival.
Despite a tough investment climate and a series of setbacks, Ardra is up to the challenge of precision fermentation.